Effect of Group Led Creative Writing on Mood in Cancer Patients
1 other identifier
interventional
60
1 country
1
Brief Summary
The primary purpose of this study is to determine whether creative writing in newly diagnosed cancer patients and those with recent progression in their disease will have a positive impact on their mental health. Using a randomized controlled trial approach, emotion thermometers will be employed to evaluate participants' responses on a number of domains, such as anxiety, depression, despair, and anger along with a series of survey questions to monitor changes in depressive and anxiety symptoms. Open-ended survey questions will be used to capture how a creative writing intervention impacts participants' experience of their illness. Melissa Greene's Write from the Heart program focuses more on creative writing rather than cancer focused topics. Patients in the intervention arm will complete -one and a half hour group sessions every two weeks over the span of 3 months. Participants in the active control arm will be provided a book (i.e., Writing Down Bones by Natalie Goldberg) about creative writing and will be asked to do activities for 1.5 hrs every 2 weeks for a period of 3 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 28, 2018
CompletedStudy Start
First participant enrolled
March 28, 2018
CompletedFirst Posted
Study publicly available on registry
May 25, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 16, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
November 16, 2018
CompletedResults Posted
Study results publicly available
October 20, 2020
CompletedOctober 20, 2020
October 1, 2020
8 months
March 28, 2018
June 26, 2020
October 16, 2020
Conditions
Outcome Measures
Primary Outcomes (6)
Emotional Thermometer Subscale 1- Distress at Final
Mood scores before and after intervention (after completion of entire session this may vary as some patients may not be able to complete six sessions). A validated Emotional Thermometer Scales (ETS) will be used to predict changes pre and post-intervention. The validated ETS has five dimensions (distress, anxiety, depression,anger, need help), which are all continuous variables and range from 0 to 10 with 0 being no emotional symptoms and 10 extremely emotional. Individual scores will be analyzed as well as a sum of the five scores will be collected to represent average mood score.
4 months
Emotional Thermometer Subscale 2 - Anxiety at Final
Mood scores before and after intervention (after completion of entire session this may vary as some patients may not be able to complete six sessions). A validated Emotional Thermometer Scales (ETS) will be used to predict changes pre and post-intervention. The validated ETS has five dimensions (distress, anxiety, depression,anger, need help), which are all continuous variables and range from 0 to 10 with 0 being no emotional symptoms and 10 extremely emotional. Individual scores will be analyzed as well as a sum of the five scores will be collected to represent average mood score.
4 months
Emotional Thermometer Subscale 3 - Depression at Final
Mood scores before and after intervention (after completion of entire session this may vary as some patients may not be able to complete six sessions). A validated Emotional Thermometer Scales (ETS) will be used to predict changes pre and post-intervention. The validated ETS has five dimensions (distress, anxiety, depression,anger, need help), which are all continuous variables and range from 0 to 10 with 0 being no emotional symptoms and 10 extremely emotional. Individual scores will be analyzed as well as a sum of the five scores will be collected to represent average mood score.re.
4 months
Emotional Thermometer Subscale 4-anger at Final
Mood scores before and after intervention (after completion of entire session this may vary as some patients may not be able to complete six sessions). A validated Emotional Thermometer Scales (ETS) will be used to predict changes pre and post-intervention. The validated ETS has five dimensions (distress, anxiety, depression,anger, need help), which are all continuous variables and range from 0 to 10 with 0 being no emotional symptoms and 10 extremely emotional. Individual scores will be analyzed as well as a sum of the five scores will be collected to represent average mood score..
4 months
Emotional Thermometer Subscale 5-need Help at Final
Mood scores before and after intervention (after completion of entire session this may vary as some patients may not be able to complete six sessions). A validated Emotional Thermometer Scales (ETS) will be used to predict changes pre and post-intervention. The validated ETS has five dimensions (distress, anxiety, depression,anger, need help), which are all continuous variables and range from 0 to 10 with 0 being no emotional symptoms and 10 extremely emotional. Individual scores will be analyzed as well as a sum of the five scores will be collected to represent average mood score.
4 months
Emotional Thermometer Score (Total) at Final
Mood scores before and after intervention (after completion of entire session this may vary as some patients may not be able to complete six sessions). A validated Emotional Thermometer Scales (ETS) will be used to predict changes pre and post-intervention. The validated ETS has five dimensions (distress, anxiety, depression,anger, need help), which are all continuous variables and range from 0 to 10 with 0 being no emotional symptoms and 10 extremely emotional. Individual scores will be analyzed as well as a sum of the five scores will be collected to represent average mood score.score.
4 months
Secondary Outcomes (4)
Depression Symptoms
4 months
Anxiety Symptoms
4 months
Self Reported Somatic Symptoms at Final
4 months
Depression Symptoms at Final
4 months
Other Outcomes (6)
Status of Cancer at Consent
consent
Number of Subjects Who Were Admitted to the Hospital and ER Admissions During Study Time
4 months
Number of Subject That Were Not Hospital or ER Admissions After Study
4 months
- +3 more other outcomes
Study Arms (2)
Creative Writing Workshop
EXPERIMENTALThe intervention arm will receive a dedicated workshop for one and a half hours every 2 weeks for 3 months.
Independent Writing - Control Group
ACTIVE COMPARATORThe control arm will receive a book (i.e., Writing Down Bones by Natalie Goldberg) on creative writing and asked to read and do writing activities for one and a half hours once every two weeks for 3 months.
Interventions
This group will participate in a writing workshop in group sessions.
This group will receive a book for a self writing session.
Eligibility Criteria
You may qualify if:
- Newly diagnosed with any stage or type of cancer within 3 months OR progression of disease within 3 months of enrollment. Recurrence of cancer within 3 months of enrollment would also be eligible as it will be considered as progression of cancer Ability to understand English language and ability to write without any functional difficulty ECOG performance status 0-3
You may not qualify if:
- Inability to give informed consent Severe psychiatry illness (e.g., uncontrolled depression, schizophrenia or psychosis) Severe cognitive impairment Pregnant females Inability to write or understand English
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Penn State Cancer Institute
Hershey, Pennsylvania, 17033, United States
Related Publications (1)
DOI: 10.1200/JCO.2017.35.31_suppl.178 Journal of Clinical Oncology 35, no. 31_suppl (November 2017) 178-178.
RESULT
Related Links
Results Point of Contact
- Title
- Monika Joshi, MD, MRCP
- Organization
- MS Hershey Medical Center
Study Officials
- PRINCIPAL INVESTIGATOR
Monika Joshi, MD
Penn State Hershey Cancer Institute
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor, Department of Medicine, Division of Hematology-Oncology
Study Record Dates
First Submitted
March 28, 2018
First Posted
May 25, 2018
Study Start
March 28, 2018
Primary Completion
November 16, 2018
Study Completion
November 16, 2018
Last Updated
October 20, 2020
Results First Posted
October 20, 2020
Record last verified: 2020-10
Data Sharing
- IPD Sharing
- Will not share